Last reviewed · How we verify
NCT04193332
Near Infrared (NIR) Autofluorescence Image-guided Thyroid Surgery
NA trial testing NIR optical imaging camera in Hypoparathyroidism Postprocedural in 214 participants. Status unknown.
1 October 2023
Quick facts
| Lead sponsor | Rigshospitalet, Denmark |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 214 |
| Start date | 16 August 2019 |
| Primary completion | 1 October 2023 |
| Estimated completion | 1 December 2023 |
| Sites | 2 locations across Denmark |
Drugs / interventions tested
- NIR optical imaging camera
Conditions studied
- Hypoparathyroidism Postprocedural — all drugs for Hypoparathyroidism Postprocedural →
- Hypocalcemia — all drugs for Hypocalcemia →
- Surgery--Complications — all drugs for Surgery--Complications →
Sponsor
Rigshospitalet, Denmark
Who can join
18 and older, any sex, with Hypoparathyroidism Postprocedural or Hypocalcemia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this ongoing randomized controlled trial is to examine whether the use of intra-operative NIR(near infrared) camera can reduce the number of patients who experience transient or persistent hypoparathyroidism after total thyroidectomy and completion thyroidectomy, both in malignant and benign thyroid disease.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effect of near infrared autofluorescence guided total thyroidectomy on postoperative hypoparathyroidism: a randomized clinical trial.
Lykke E, Christensen A, Juhl K, Feldt-Rasmussen U, et al · · 2023 · cited 14× · PMID 36853388 · DOI 10.1007/s00405-023-07867-4
Verify or expand the search:
- PubMed search for NCT04193332
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hypoparathyroidism Postprocedural
Currently open trials in the same condition.
- NCT06961071 — Parathyroid Allotransplant for Treatment of Hypoparathyroidism · Phase 1, PHASE2 · recruiting
- NCT05117853 — Autofluorescence and Indocyanine Green to Avoid Hypocalcemia After Thyroidectomy · Phase 3 · recruiting
- NCT03249012 — Quality of Life Related to Different Treatment Protocols for Post-thyroidectomy Hypoparathyroidism · NA · recruiting
Other Rigshospitalet, Denmark trials
Trials by the same sponsor.
- NCT07401368 — Clinicians' Trust in AI-Based Fetal Growth Estimates · NA · not yet recruiting
- NCT07442357 — The Per-procedural Antibiotic Prophylaxis in Patients Undergoing Transcatheter Aortic Valve Implantation Trial · NA · not yet recruiting
- NCT07528729 — Alcohol as a Modifiable Risk Factor for Atrial Fibrillation · NA · not yet recruiting
- NCT07511439 — Reversible Effects of Oral Contraceptive Removal on Serotonergic Neurotransmission · Phase 4 · not yet recruiting
- NCT07467187 — Invasive Home Ventilation in Denmark · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04193332 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rigshospitalet, Denmark
- Last refreshed: 14 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04193332.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing